UGC Approved Journal no 63975(19)

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 11 | Issue 10 | October 2024

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 4 Issue 9
September-2017
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR1709068


Registration ID:
170693

Page Number

431-438

Share This Article


Jetir RMS

Title

A Comparative Clinical Study of Qurs-E-Zarishk and Ursodeoxycholic Acid in Non Alcoholic Fatty Liver Disease

Abstract

Nonalcoholic fatty liver disease (NAFLD) is now considered as a hepatic feature of metabolic syndrome and is a clinical spectrum ranging from simple steatosis (Non Alcoholic Fatty Liver, NAFL) to Non Alcoholic Steatohepatitis (NASH) . The former has a benign prognosis but latter is associated with fibrosis and progression to liver cirrhosis and hepatocellular carcinoma (HCC). NAFLD is a rapidly growing disease in both developed and developing countries and is probably the most common cause of abnormal liver function tests worldwide. The prevalence of NAFLD appears to be increasing in parallel with the epidemics of obesity. Now it has become the most common cause of chronic liver disease after hepatis B, hepatitis C and alcohol. In Unani Medicine a number of herbal drugs, plants as a whole or their parts are extensively used for the cure of liver derangement, and are scientifically evaluated for their safety and efficacy. In the present study, a comparative therapeutic evaluation of Qurs-e-Zarishk and Ursodeoxycholic Acid (UDCA) in 60 patients of Nonalcoholic fatty liver was done. The study shows that the Unani Test Formulation ‘Qurs-e-Zarishk’ produces significant improvement in cases of Nonalcoholic fatty liver. Comparison of Qurs-e-Zarishk with the standard agent UDCA shows that in the most parameters, the later is more effective while in some parameters Qurs-e-Zarishk is more effective. Keywords: Unani Medicine, NAFLD, Ursodeoxycholic Acid (UDCA), NASH, Qurs-e-Zarishk.

Key Words

Unani Medicine, NAFLD, Ursodeoxycholic Acid (UDCA), NASH, Qurs-e-Zarishk.

Cite This Article

"A Comparative Clinical Study of Qurs-E-Zarishk and Ursodeoxycholic Acid in Non Alcoholic Fatty Liver Disease", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.4, Issue 9, page no.431-438, September-2017, Available :http://www.jetir.org/papers/JETIR1709068.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"A Comparative Clinical Study of Qurs-E-Zarishk and Ursodeoxycholic Acid in Non Alcoholic Fatty Liver Disease", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.4, Issue 9, page no. pp431-438, September-2017, Available at : http://www.jetir.org/papers/JETIR1709068.pdf

Publication Details

Published Paper ID: JETIR1709068
Registration ID: 170693
Published In: Volume 4 | Issue 9 | Year September-2017
DOI (Digital Object Identifier):
Page No: 431-438
Country: Aligarh, Uttar Pradesh, India .
Area: Medical Science
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

0004680

Print This Page

Current Call For Paper

Jetir RMS